Mylan chief executive Heather Bresch said one thing at a contentious hearing last week that could quell criticism from people with life-threatening allergies: Mylan will soon push to extend the shelf life for EpiPen.
EpiPens currently expire 18 months after their date of manufacture. Facing outrage from patients and politicians for the drug’s rapidly rising price, Bresch said the company hopes to extend this to a minimum of 24 months.
To make the change, Mylan will need to convince federal regulators that its data demonstrates that a new EpiPen formulation can remain effective for months longer.
